Funding, M&A, exec moves and hiring — every signal, the moment it breaks.See plans →
LifeMine Therapeutics Inc. raises $263 million in a funding round to accelerate the clinical development of LIFE-001 and advance its pipeline.
PRIVATEAug 06, 2026•2 days ago
Amount Raised
$263 Million
Round Type
Venture - Series Unknown
Description
LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company, announced $263 million in financing. The funding will be used to accelerate the clinical development of their lead program, LIFE-001. This program is designed to transform organ transplantation. The financing will also help advance their pipeline of novel transplantation and immunology therapies.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching LifeMine Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan